Results 171 to 180 of about 109,884 (230)

Enfermedad cardiovascular y Lipoproteína (a)

Introducción. La Lp(a) es una molécula lipídica similar a la LDL. Los niveles elevados de esta se asocian con un mayor riesgo de enfermedad cardiovascular. Se encuentra elevada en el 20-25% de la población, por lo que nuestro objetivo principal es investigar si la Lp(a) puede ser en la práctica clínica una diana terapéutica para la disminución del ...
openaire   +1 more source

Impact of seasonal temperature variations on adverse outcomes in atrial fibrillation: comparative insights from Vigo and Murcia cohorts. [PDF]

J Glob Health
Soler-Espejo E, Ramos-Bratos MP, González-Bermúdez I, Rivera-Caravaca JM, Domínguez-Erquicia P, Íñiguez-Romo A, Marín F, Roldán V, Raposeiras-Roubín S.   +8 more
europepmc   +1 more source

Corrigendum to "Three-dimensional aortic geometry mapping via registration of non-gated contrast-enhanced or gated and respiratory-navigated MR angiographies" [Journal of Cardiovascular Magnetic Resonance 26 (2024) 100992]. [PDF]

J Cardiovasc Magn Reson
Dux-Santoy L, Rodríguez-Palomares JF, Teixidó-Turà G, Garrido-Oliver J, Carrasco-Poves A, Morales-Galán A, Ruiz-Muñoz A, Casas G, Valente F, Galian-Gay L, Fernández-Galera R, Oliveró R, Cuéllar-Calabria H, Roque A, Burcet G, Barrabés JA, Ferreira-González I, Guala A.   +17 more
europepmc   +1 more source

Correction: Povo-Retana et al. Trabectedin and Lurbinectedin Modulate the Interplay between Cells in the Tumour Microenvironment-Progresses in Their Use in Combined Cancer Therapy. <i>Molecules</i> 2024, <i>29</i>, 331. [PDF]

Molecules
Povo-Retana A, Landauro-Vera R, Alvarez-Lucena C, Cascante M, Boscá L.   +4 more
europepmc   +1 more source

Factores asociados al Control de la Hipertensión Arterial Sistémica en Pacientes con Diabetes Mellitus tipo 2 en el Centro de Salud Emiliano Zapata, 2012. [PDF]

, 2013
Hernández Ortíz, Manuel Fermín, Pimentel Ramírez, María Luisa   +1 more
core  

Impact of Pre-Heart Transplant Levosimendan Administration on Post-Transplant Vasoplegia and Primary Graft Dysfunction. [PDF]

Clin Transplant
Guzman-Bofarull J, Martín-Centellas A, Couto-Mallon D, Borràs R, Arenas-Loriente A, Rivas-Lasarte M, Segovia-Cubero J, Crespo-Leiro MG, García-Álvarez A, Farrero M.   +9 more
europepmc   +1 more source

Aspectos biológicos y clínicos de las diferencias [PDF]

, 2003
Valls Llobet, Carme
core  

Correction: Early initiation of SGLT2 inhibitors within guideline-directed medical therapy and outcomes in newly diagnosed heart failure patients. [PDF]

BMC Cardiovasc Disord
Esteban-Fernández A, López-Fernández S, Pastor-Pérez FJ, Pérez-Rivera JÁ, Bonilla-Palomas JL, Cobo-Marcos M, García-Pinilla JM, Almenar-Bonet L, Fluviá-Brugués P, Bermúdez-Jiménez FJ, Goena-Vives C, López-López A, Gómez-Otero I, TIDY-HF researchers.   +13 more
europepmc   +1 more source

Fundamental Anatomy and Its Impact on Clinical Practice: Myocardial Bridging. [PDF]

JACC Case Rep
Ortega-Pérez R, Ibañez B, Sánchez-Quintana D, Cabrera JÁ.   +3 more
europepmc   +1 more source

Improvement of Heart Failure Discrimination by the Integration of the Left Ventricle Global Longitudinal Strain. [PDF]

Clin Pract
Cordero A, Quintanilla MA, Torres C, López N, Bodí C, Bixquert G, Lopez-Ayala JM.   +6 more
europepmc   +1 more source